000 01613 a2200445 4500
005 20250513152011.0
264 0 _c19980924
008 199809s 0 0 eng d
022 _a0887-6924
024 7 _a10.1038/sj.leu.2401126
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aThomas, X
245 0 0 _aInfluence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia.
_h[electronic resource]
260 _bLeukemia
_cSep 1998
300 _a1503-6 p.
_bdigital
500 _aPublication Type: Case Reports; Letter; Comment
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAmsacrine
_xadministration & dosage
650 0 4 _aAntibiotics, Antineoplastic
_xadverse effects
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aBody Mass Index
650 0 4 _aCytarabine
_xadministration & dosage
650 0 4 _aDaunorubicin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHeart
_xdrug effects
650 0 4 _aHeart Failure
_xchemically induced
650 0 4 _aHumans
650 0 4 _aLeukemia, Promyelocytic, Acute
_xcomplications
650 0 4 _aMale
650 0 4 _aMercaptopurine
_xadministration & dosage
650 0 4 _aObesity
_xcomplications
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xdrug therapy
650 0 4 _aRemission Induction
650 0 4 _aTretinoin
_xadministration & dosage
700 1 _aFiere, D
700 1 _aArchimbaud, E
773 0 _tLeukemia
_gvol. 12
_gno. 9
_gp. 1503-6
856 4 0 _uhttps://doi.org/10.1038/sj.leu.2401126
_zAvailable from publisher's website
999 _c9702753
_d9702753